Wanda Terrell
Internal Medicine · Saint Louis, MONPI 1558391938
Payments from drug & device makers
Across 401 payments — averaging $14.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$844
- Novo Nordisk$701
- Pfizer$645
- GSK$606
- AbbVie$496
- Lilly USA, LLC$372
- plus $2K from 30 others
What the payments were for
- Food & beverage$5,85298%
- Education$1152%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 51 | $844 |
| Novo Nordisk | 51 | $701 |
| Pfizer | 42 | $645 |
| GSK | 51 | $606 |
| AbbVie(2 entities) | 36 | $496 |
| Lilly USA, LLC | 25 | $372 |
| Boehringer Ingelheim | 18 | $297 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $286 |
| Biohaven Pharmaceuticals, Inc. | 11 | $216 |
| Sanofi-aventis U.S. LLC | 12 | $203 |
| Astellas Pharma US Inc | 8 | $189 |
| Arbor Pharmaceuticals, Inc. | 14 | $185 |
| Merck | 10 | $148 |
| Johnson & Johnson | 7 | $102 |
| Sunovion Pharmaceuticals Inc. | 7 | $97 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $87 |
| Amgen | 4 | $66 |
| Amarin Pharma, Inc. | 4 | $53 |
| Bristol Myers Squibb | 1 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Shire North American Group Inc | 2 | $32 |
| Dexcom, Inc. | 2 | $27 |
| Daiichi Sankyo Inc. | 2 | $25 |
| Zyla Life Sciences, Inc. | 2 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Novartis | 1 | $19 |
| Abbott | 1 | $18 |
| Edwards Lifesciences | 1 | $17 |
| Genentech USA, Inc. | 1 | $17 |
| Optos, Inc. | 1 | $14 |
| Bayer | 1 | $14 |
| Gilead | 1 | $12 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
| Mylan Specialty L.p. | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
How this compares
$5,966 in reported general payments places this provider in the 90th percentile of 2,097 internal medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 17 | $262 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Saint Louis
- Michael ReschakSaint Louis$3.1M
- David PrelutskySaint Louis$575K
- Danish JabbarSaint Louis$510K
- Hany SalamaSaint Louis$279K
- Lauren LevineSaint Louis$264K
- Brij VaidSaint Louis$213K
- Vinay KamatSaint Louis$191K
- Tracy NorfleetSaint Louis$132K
- Paul OlivoSaint Louis$98K
- Priyanka RavalSaint Louis$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.